Conference Reports for NATAP

13th IAS Conference on HIV Science IAS 2026 July 26-31 Rio, Brazil Back

Baseline Demographics in the Phase 2b Registrational EXTEND 4M Trial: Evaluating a Novel Every-4-Month Cabotegravir Formulation in a Population Who Could Benefit From PrEP       AS 2026 Rio, Brazil